About this site
Wiley is using this site to highlight newly published content related to the current COVID-19 outbreak. The most recent articles can be found below. From the navigation menu above, you will find links to archived content from the past few months, as well as Special Collections compiled by several individual journals and organizations. In addition to this site, Wiley is also making a collection of journal articles and our book chapters on coronavirus research freely available to the global scientific community.
In response to the call to action from OSTP and other governments, Wiley is also feeding content into PubMed Central as it comes in and licensing it to maximize discoverability and usability.
For more information on how Wiley's services have been adjusted due to COVID-19, please see our FAQ.
Novel Coronavirus Outbreak
Most recent articles (newest articles listed first)
COVID‐19 vaccination: Evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients
Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS‐CoV‐2 vaccination in patients with chronic hepatitis B virus infection
Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?
Alignment of human KAT2A (GCN5) histone acetyltransferase and SARS‐CoV‐2 Orf8 viral proteins
The influence of COVID-19 on modes of governance for climate change—Expert views from the Netherlands and the UK
Evidence‐based prescription of corticosteroids for COVID‐19 patients: A comparison between general medicine and other specialty in Japan
The salivary and nasopharyngeal microbiomes are associated with SARS‐CoV‐2 infection and disease severity
Weekly symptom profiles of nonhospitalized individuals infected with SARS‐CoV‐2 during the Omicron outbreak in Hong Kong: A retrospective observational study from a telemedicine center
Side effects following COVID‐19 vaccination in pediatric patients with sickle cell disease
Pathways to food insecurity: Migration, hukou and COVID‐19 in Nanjing, China
SARS‐CoV‐2 Virus Detection Via a Polymeric Nanochannel‐Based Electrochemical Biosensor
An electrochemical biosensor was constructed by convectively assembling polystyrene (PS) beads on a gold electrode to detect SAR-Cov-2 virus via partial nanochannel blockage by virus particles. Nanochannel blockage hinders the diffusion of a redox probe and causes attenuation of oxidation current, allowing quantification of the viral load by measuring the changes in oxidation currents before and after virus incubation.
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production
The safety of COVID‐19 vaccination in immunocompromised children and young adults with immune‐mediated inflammatory disease
High flow nasal cannula for acute respiratory failure due to COVID‐19 in patients with a ‘do‐not‐intubate’ order: A survival analysis
High flow nasal cannula (HFNC) reduces the need for intubation in patients with hypoxaemic acute respiratory failure (ARF). Our data suggest that a trial of HFNC could be considered to increase chances of survival in patients with ARF due to coronavirus disease 2019 (COVID-19) pneumonitis and a do-not-intubate (DNI) order, especially in those with a good WHO performance status.
Learning from adversity: What the COVID-19 pandemic can teach us about family resiliency
Adverse event reports of anaphylaxis after Comirnaty and Vaxzevria COVID-19 vaccinations, Western Australia, 22 February to 30 June 2021
COVID‐19: Implications for Nursing and Health Care in the United States
Experiencing and witnessing disruptive behaviors toward nurses in COVID‐19 teams, patient safety, and errors in care
Surveillance for SARS‐CoV‐2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks
Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS‐CoV‐2 Omicron variants
A novel, ultrafast, ultrasensitive diagnosis platform for the detection of SARS‐COV‐2 using restriction endonuclease‐mediated reverse transcription multiple cross displacement amplification
Dynamics of nosocomial SARS‐CoV‐2 transmissions: Facing the challenge of variants of concern in a Brazilian reference hospital
How can patient partnership help to improve equality as COVID‐19 moves from pandemic to endemic?
SARS‐CoV‐2 and omicron variant detection with a high selectivity, sensitivity, and low‐cost silicon bio‐nanosensor
Synthetic SARS-CoV-2 and Omicron variant detection with a cost-effective silicon nanowire sensor has been demonstrated with high sensitivity, selectivity, and a fast response. The sensor reaches a 4 cps limit of detection (LoD), even for the Omicron variant, without any genome amplification, and with strong selectivity. The platform is made with industrially compatible techniques, which in perspective may allow a widespread diffusion.